Marc A. Becker

Insider Reports History

Entity
Individual
Location
175 Crossing Blvd., 4 Th Floor, Framingham, MA
Signature
/s/ Jeffrey A. Munsie, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marc A. Becker:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CONCERT PHARMACEUTICALS, INC. Chief Financial Officer Common Stock 0 $8.33 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Chief Financial Officer Performance Stock Units 0 Mar 6, 2023 Direct
CONCERT PHARMACEUTICALS, INC. Chief Financial Officer Stock Option (Right to Buy) 0 Mar 6, 2023 Direct

Insider Reports Filed by Marc A. Becker

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNCE CONCERT PHARMACEUTICALS, INC. Mar 6, 2023 7 $0 4 Mar 6, 2023 Chief Financial Officer
CNCE CONCERT PHARMACEUTICALS, INC. Feb 15, 2023 1 -$31.3K 4 Feb 16, 2023 Chief Financial Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 30, 2023 1 -$70.9K 4 Jan 31, 2023 Chief Financial Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 6, 2023 1 -$21K 4 Jan 9, 2023 Chief Financial Officer
CNCE CONCERT PHARMACEUTICALS, INC. Feb 14, 2022 1 -$11.6K 4 Feb 16, 2022 Chief Financial Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 28, 2022 2 $0 4 Feb 1, 2022 Chief Financial Officer
CNCE CONCERT PHARMACEUTICALS, INC. Jan 5, 2022 1 -$9.26K 4 Jan 7, 2022 Chief Financial Officer
CNCE CONCERT PHARMACEUTICALS, INC. Aug 16, 2021 1 -$24K 4 Aug 17, 2021 Chief Financial Officer